Sobi is a global biopharmaceutical company that specializes in the development and commercialization of innovative therapies for rare diseases. The company has a strong focus on hematology, immunology, and genetic diseases.
Sobi has a pipeline of promising therapies in development, and it is committed to bringing new and effective treatments to patients with rare diseases. The company is headquartered in Stockholm, Sweden, and has offices in other major cities around the world.
Sobi is a leading player in the rare disease market. The company is committed to providing patients with access to innovative therapies and improving their quality of life.